A Common Osteoporosis Drug Might Be the Secret to Ending Chronic Back Pain

New research shows how bone cells can literally push back against pain

Low back pain can be stubbornly mysterious. For millions of people, the ache persists for years, even when doctors can’t find a single structural problem, even on an MRI. It’s like a ghost, but scientists may have finally found a way to track this ghost.

A new study suggests that as our spinal hardware breaks down, pain-sensing nerves go where they don’t belong. They crawl into the damaged tissue of the vertebral endplates.

There’s also some good news: a hormone treatment already sitting on pharmacy shelves for osteoporosis might be able to chase them away.

A Spine Under Siege

The study focuses on parathyroid hormone, or PTH. This hormone regulates how our bodies swap out old bone for new. Doctors already prescribe synthetic PTH to strengthen brittle bones, but researchers have long suspected it does something more. They just didn’t know how it quieted pain.

To investigate, Dr. Janet L. Crane of Johns Hopkins University School of Medicine and her colleagues turned to three mouse models of spinal degeneration: old mice, mice with surgically induced instability in the lower spine, and a strain genetically prone to early spinal wear. They gave the mice daily PTH injections for up to two months.

The results were striking across all three models. The treated mice developed stronger vertebral endplates (the thin structures between the spinal discs and vertebrae). These endplates became less porous and more structurally sound. The mice also felt less pain. They stayed on their running wheels longer and showed a higher tolerance for pressure. Their spines looked healthier, and their behavior proved it.

The “Go Away” Signal

The team then zoomed in on the nerves themselves. In a crumbling spine, pain-sensing fibers start to move into areas they shouldn’t. But PTH acted like a barrier. The hormone significantly reduced these rogue fibers, specifically those carrying the chemical “calling cards” of chronic pain, known as PGP9.5 and CGRP.

“During spinal degeneration, pain-sensing nerves grow into regions where they normally do not exist. Our findings show that parathyroid hormone can reverse this process by activating natural signals that push these nerves away,” Dr. Crane said.

×

Get smarter every day...

Stay ahead with ZME Science and subscribe.

Daily Newsletter
The science you need to know, every weekday.

Weekly Newsletter
A week in science, all in one place. Sends every Sunday.
No spam, ever. Unsubscribe anytime. Review our Privacy Policy.

Thank you! One more thing...

Please check your inbox and confirm your subscription.

PTH did not act directly on the nerves. Instead, it spurred osteoblasts, bone building cells, to produce a protein called Slit3. That protein works like a biochemical warning flare, telling growing nerve fibers to steer clear. When the researchers exposed nerve cells to Slit3 in the lab, the fibers grew shorter and became less invasive.

The researchers also looked at how the hormone produced this effect. PTH prompted bone-building cells to make more Slit3. When the team blocked that process (either by preventing those cells from responding properly to PTH or by stopping them from making Slit3) the treatment no longer improved the endplates as much, no longer reduced nerve growth, and no longer eased pain-related symptoms in the mice.

That result sharpened the paper’s central argument: bone cells are not passive bricks in the spine. They are active participants in pain.

Why This Matters a Lot

The study was only carried out on mice, and the findings may not translate to humans (or not perfectly). But the idea fits with the group’s earlier work on spinal degeneration. In prior studies, the researchers showed that cells that break down bone can release molecules that attract nerves into diseased tissue.

In the new work, osteoblasts seem to provide the opposite force, repelling those fibers when PTH nudges them into action. Chronic back pain, in this view, emerges partly from a shifting tug-of-war between the signals that lure nerves in and the signals that drive them back.

RelatedPosts

Scientists Create Mice with Two Fathers in a Genetic Breakthrough That Could Save Endangered Species
Women Experience Longer Lasting Pain Than Men and Scientists Think They Finally Know the Reason Why
A pharmacy under your skin – microchip implanted in patients delivers drugs
A Hidden Bone Receptor Could Open The Door To Reversing Osteoporosis

Low back pain is among the world’s most common medical complaints, and much of it falls into the frustrating category of “nonspecific” pain, where no single anatomical problem cleanly explains the suffering. The new study does not solve that problem. It does, however, offer a biologically rich explanation for how degeneration in the spine can become painful even when the damage is not dramatic on a scan.

Some people taking PTH-like drugs for osteoporosis have reported less back pain, a pattern the authors note may now be easier to understand. But the evidence in humans remains uneven. The researchers themselves emphasize that clinical trials will be needed before anyone can say whether PTH could become a real treatment for chronic low back pain.

The study was published in the journal Bone Research.